Sanofi Taps Jubilant Expertise For Metabolic Disorder Drug Discovery
This article was originally published in PharmAsia News
Executive Summary
India's biggest contract research firm Jubilant Life Sciences says it has joined forces with the German arm of France's biggest pharma firm Sanofi to discover new therapies for treating metabolic disorders.